프로톤 펌프 저해제 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 약제 유형별, 질환별, 용도별, 지역별, 경쟁별 세분화(2020-2030년)
Proton Pump Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Disease Allocation, By Application, By Region and Competition, 2020-2030F
상품코드:1886435
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 프로톤 펌프 저해제 시장은 2024년에 31억 5,000만 달러로 평가되며, 2030년까지 CAGR 4.87%로 성장하며, 41억 9,000만 달러에 달할 것으로 예측됩니다. 양성자 펌프 억제제는 위벽 세포의 수소/칼륨 아데노신 삼인산 가수분해효소(H+/K+-ATPase) 효소계를 비가역적으로 억제하여 위산 분비를 억제하도록 설계된 의약품 화합물의 일종입니다. 위식도 역류질환, 소화성 궤양, 기타 산 관련 위장 질환의 세계 유병률 증가와 이러한 질환에 취약한 고령 인구 증가로 인해 이러한 약물 세계 시장이 성장하고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
31억 5,000만 달러
시장 규모 : 2030년
41억 9,000만 달러
CAGR : 2025-2030년
4.87%
가장 빠르게 성장하는 부문
에스오메프라졸
최대 시장
북미
주요 시장 성장 촉진요인
세계 프로톤 펌프억제제(PPI) 시장은 위식도역류질환(GERD) 및 소화성 궤양 유병률 증가와 고령화 인구 증가에 따른 위장장애 감수성 증가에 힘입어 괄목할 만한 성장세를 보이고 있습니다. GERD, 소화성 궤양 등의 질환의 광범위한 발생은 산 관련 증상 관리 및 치유 촉진에 있으며, PPI의 효능을 고려할 때 PPI에 대한 근본적인 수요를 형성하고 있습니다.
주요 시장 과제
양성자 펌프 억제제의 장기적인 안전성 프로파일은 시장 확대에 있으며, 중요한 과제가 되고 있습니다. 장기 사용에 따른 잠재적 부작용에 대한 임상적 증거 증가와 규제 당국의 감시 강화는 의료 서비스 프로바이더의 처방 패턴에 점점 더 많은 영향을 미치고 있습니다.
주요 시장 동향
첨단 PPI 제제 및 전달 시스템의 혁신은 치료 프로파일을 개선하고, 환자의 복약 순응도를 개선하며, 잠재적인 장기 부작용을 줄이기 위한 제약업계의 지속적인 노력에 의해 주도되고 있는 중요한 추세입니다. 이 초점에는 약효 발현을 빠르게 하거나 약효 지속 시간을 연장하는 새로운 약물전달 시스템 및 제형 개발이 포함됩니다.
The Global Proton Pump Inhibitors Market, valued at USD 3.15 Billion in 2024, is projected to experience a CAGR of 4.87% to reach USD 4.19 Billion by 2030. Proton Pump Inhibitors are a class of pharmaceutical compounds designed to reduce gastric acid secretion by irreversibly blocking the hydrogen/potassium adenosine triphosphatase enzyme system of gastric parietal cells. The global market for these agents is driven by the increasing worldwide prevalence of gastroesophageal reflux disease, peptic ulcer disease, and other acid-related gastrointestinal disorders, coupled with an expanding geriatric population more susceptible to such conditions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.15 Billion
Market Size 2030
USD 4.19 Billion
CAGR 2025-2030
4.87%
Fastest Growing Segment
Esomeprazole
Largest Market
North America
Key Market Drivers
The global Proton Pump Inhibitors market experiences substantial growth, primarily propelled by the escalating prevalence of gastroesophageal reflux disease and peptic ulcers, alongside the expanding geriatric population's increased susceptibility to gastrointestinal disorders. The widespread occurrence of conditions such as GERD and peptic ulcers forms the foundational demand for PPIs, given their efficacy in managing acid-related symptoms and promoting healing. According to Frontiers, in Global, regional, and national burden of gastroesophageal reflux disease (1990-2021): age-period-cohort analysis and Bayesian projections, published in 2023, global GERD prevalence reached 825.6 million cases in 2021, underscoring the significant patient pool requiring effective acid suppression therapies.
Key Market Challenges
The long-term safety profile of Proton Pump Inhibitors presents a notable challenge to market expansion. Growing clinical evidence and heightened regulatory scrutiny regarding potential adverse effects linked to prolonged use are increasingly influencing prescribing patterns among healthcare providers. This necessitates more cautious consideration during patient consultations and can lead to reduced initiation of long-term PPI therapy. Consequently, patient adherence may also be impacted, as individuals become more aware of reported risks, potentially leading to earlier discontinuation of treatment. These dynamics directly impede the sustained growth of the Global Proton Pump Inhibitors Market by tempering the volume of new prescriptions and the duration of existing ones.
Key Market Trends
Innovation in advanced PPI formulations and delivery represents a crucial trend, driven by the pharmaceutical industry's continuous efforts to enhance therapeutic profiles, improve patient adherence, and mitigate potential long-term side effects. This focus includes developing novel drug delivery systems and formulations that offer faster onset of action or prolonged efficacy. For example, Takeda Pharmaceutical Company Limited, in its first-quarter fiscal year 2025 results announced in July 2025, reaffirmed its commitment to discovering and delivering life-transforming treatments in its core therapeutic areas, explicitly including gastrointestinal and inflammation, highlighting ongoing innovation in this critical space.
Key Market Players
Bayer AG
AstraZeneca PLC
Pfizer, Inc.
Eli Lilly and Co Ltd
Teva Pharmaceutical Industries Ltd
Cadila Pharmaceuticals Ltd
Johnson & Johnson
Takeda Pharmaceutical Co Ltd
Eisai Co Ltd
Report Scope:
In this report, the Global Proton Pump Inhibitors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Proton Pump Inhibitors Market, By Drug Type:
Pantoprazole
Omeprazole
Lansoprazole Esomeprazole Rabeprazole
Dexlansoprazole Others
Proton Pump Inhibitors Market, By Disease Allocation:
Ulcers
Gastroesophageal Reflux Disease
Others
Proton Pump Inhibitors Market, By Application:
Hospitals
Clinic
Others
Proton Pump Inhibitors Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Proton Pump Inhibitors Market.
Available Customizations:
Global Proton Pump Inhibitors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Proton Pump Inhibitors Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Type (Pantoprazole, Omeprazole, Lansoprazole Esomeprazole Rabeprazole, Dexlansoprazole, Others)
5.2.2. By Disease Allocation (Ulcers, Gastroesophageal Reflux Disease, Others)
5.2.3. By Application (Hospitals, Clinic, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Proton Pump Inhibitors Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type
6.2.2. By Disease Allocation
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Proton Pump Inhibitors Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Type
6.3.1.2.2. By Disease Allocation
6.3.1.2.3. By Application
6.3.2. Canada Proton Pump Inhibitors Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Type
6.3.2.2.2. By Disease Allocation
6.3.2.2.3. By Application
6.3.3. Mexico Proton Pump Inhibitors Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Type
6.3.3.2.2. By Disease Allocation
6.3.3.2.3. By Application
7. Europe Proton Pump Inhibitors Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Disease Allocation
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Proton Pump Inhibitors Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Disease Allocation
7.3.1.2.3. By Application
7.3.2. France Proton Pump Inhibitors Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Disease Allocation
7.3.2.2.3. By Application
7.3.3. United Kingdom Proton Pump Inhibitors Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Disease Allocation
7.3.3.2.3. By Application
7.3.4. Italy Proton Pump Inhibitors Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Disease Allocation
7.3.4.2.3. By Application
7.3.5. Spain Proton Pump Inhibitors Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Disease Allocation
7.3.5.2.3. By Application
8. Asia Pacific Proton Pump Inhibitors Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Disease Allocation
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Proton Pump Inhibitors Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Disease Allocation
8.3.1.2.3. By Application
8.3.2. India Proton Pump Inhibitors Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Disease Allocation
8.3.2.2.3. By Application
8.3.3. Japan Proton Pump Inhibitors Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Disease Allocation
8.3.3.2.3. By Application
8.3.4. South Korea Proton Pump Inhibitors Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Disease Allocation
8.3.4.2.3. By Application
8.3.5. Australia Proton Pump Inhibitors Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Disease Allocation
8.3.5.2.3. By Application
9. Middle East & Africa Proton Pump Inhibitors Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Disease Allocation
9.2.3. By Application
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Proton Pump Inhibitors Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Disease Allocation
9.3.1.2.3. By Application
9.3.2. UAE Proton Pump Inhibitors Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Disease Allocation
9.3.2.2.3. By Application
9.3.3. South Africa Proton Pump Inhibitors Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Disease Allocation
9.3.3.2.3. By Application
10. South America Proton Pump Inhibitors Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Disease Allocation
10.2.3. By Application
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Proton Pump Inhibitors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Disease Allocation
10.3.1.2.3. By Application
10.3.2. Colombia Proton Pump Inhibitors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Disease Allocation
10.3.2.2.3. By Application
10.3.3. Argentina Proton Pump Inhibitors Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Disease Allocation
10.3.3.2.3. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Proton Pump Inhibitors Market: SWOT Analysis
